Optimist Retirement Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.51M Sell
43,542
-956
-2% -$54.9K 0.97% 29
2026
Q1
$2.7M Buy
44,498
+1,568
+4% +$91.4K 1.19% 17
2025
Q4
$2.32M Sell
42,930
-2,883
-6% -$139K 1.06% 28
2025
Q3
$2.07M Buy
45,813
+4,952
+12% +$231K 0.93% 41
2025
Q2
$1.89M Buy
40,861
+1,725
+4% +$84.7K 0.91% 41
2025
Q1
$2.39M Sell
39,136
-3,792
-9% -$221K 1.19% 20
2024
Q4
$2.43M Sell
42,928
-708
-2% -$39.6K 1.15% 17
2024
Q3
$2.26M Buy
+43,636
New +$2.05M 1.02% 31
2024
Q2
Sell
-38,663
Closed -$2.1M 113
2024
Q1
$2.1M Buy
38,663
+30,673
+384% +$1.56M 1.08% 20
2023
Q4
$410K Buy
+7,990
New +$419K 0.27% 48

Other funds holding BMY

Optimist Retirement Group's BMY Position: Q2 2026 in Review

Optimist Retirement Group reduced its Bristol-Myers Squibb (BMY) stake by 2.1% in Q2 2026, selling an estimated $54.9K and leaving 43,542 shares worth $2.51M. The position accounts for 0.97% of the portfolio, ranked #29.

Optimist Retirement Group first reported a position in BMY in Q4 2023 and has held it in 10 quarters since. The position peaked at $2.7M in Q1 2026. 2,521 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Optimist Retirement Group held 43,542 shares of Bristol-Myers Squibb worth $2.51M as of Q2 2026.
  • Optimist Retirement Group sold 956 Bristol-Myers Squibb shares in Q2 2026, an estimated $54.9K.
  • Bristol-Myers Squibb made up 0.97% of Optimist Retirement Group's portfolio in Q2 2026, its #29 holding.
  • Optimist Retirement Group first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 10 quarters since.
  • Optimist Retirement Group's Bristol-Myers Squibb position peaked at $2.7M in Q1 2026.
  • 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Optimist Retirement Group's 13F filing for Q2 2026, filed 10 Aug 2026.